Literature DB >> 9456104

Effects of depletion of leukocytes and platelets on cardiac dysfunction after cardiopulmonary bypass.

Y Chiba1, K Morioka, R Muraoka, A Ihaya, T Kimura, T Uesaka, T Tsuda, K Matsuyama.   

Abstract

BACKGROUND: This study examined the effects of the depletion of leukocytes and platelets from circulated blood on cardiac function after cardiopulmonary bypass in 37 patients who underwent coronary artery bypass grafting or aortic valve replacement.
METHODS: Leukocytes and platelets were removed continuously using a blood cell separator, beginning immediately after the start of the operation and ending 1 hour after the release of the aortic cross-clamp in 19 patients (LPD group), but not in the remaining 18 patients (control group). Blood cell counts and levels of thromboxane B2, 6-keto-prostaglandin F1alpha, leukocyte elastase, complements C3a and C4a, thrombin-antithrombin III complex, and D-dimer were determined periodically during and after the operation. The cardiac index, the difference between the central and peripheral core temperatures, and the doses of catecholamines and vasodilators required to support the circulation in the early postoperative period also were assessed.
RESULTS: Leukocyte and platelet counts and levels of leukocyte elastase, thromboxane B2, thromboxane2/6-ketoprostaglandin F1alpha, thrombin-antithrombin III complex, and D-dimer were significantly lower in the LPD group than in the control group before and after the release of the aortic cross-clamp and during the perioperative period. There were no significant differences in the levels of 6-keto-prostaglandin F1alpha or complements C3a and C4a between the two groups. The catecholamine dose was significantly lower in the LPD group than in the control group (1.1 +/- 2.5 versus 5.0 +/- 5.2 mg/kg, respectively). Fewer patients required the use of nitroprusside as a vasodilator in the LPD group than in the control group (1/19 versus 12/18, respectively).
CONCLUSIONS: The depletion of leukocytes and platelets using a blood cell separator prevents the deterioration of cardiac function after cardiac operations using cardiopulmonary bypass.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9456104     DOI: 10.1016/s0003-4975(97)01111-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Efficacy of leukocyte-depleted terminal blood cardioplegia in congenital heart disease.

Authors:  H Yamauchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-07

2.  Increased adhesion and aggregation of platelets lacking cyclic guanosine 3',5'-monophosphate kinase I.

Authors:  S Massberg; M Sausbier; P Klatt; M Bauer; A Pfeifer; W Siess; R Fässler; P Ruth; F Krombach; F Hofmann
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

3.  Long-term leukocyte filtration should be avoided during extracorporeal circulation.

Authors:  Jiali Tang; Kaiyu Tao; Jing Zhou; Chongwei Zhang; Lina Gong; Nanfu Luo; Lei Du
Journal:  Mediators Inflamm       Date:  2013-12-26       Impact factor: 4.711

4.  Role of Endothelial Cells in Myocardial Ischemia-Reperfusion Injury.

Authors:  Arun K Singhal; J David Symons; Sihem Boudina; Bharat Jaishy; Yan-Ting Shiu
Journal:  Vasc Dis Prev       Date:  2010
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.